Search

everythinglearnresearchcommunity

for

Search:↓

Six genetic conditions are often linked to complete scalp hair loss in children.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

A rare genetic disease causes rickets and often hair loss in young children, which can improve with specific treatments.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Tofacitinib effectively treats Alopecia Areata.

Tofacitinib is effective and safe for treating alopecia areata.

Two siblings with a rare type of rickets and hair loss had low vitamin D levels, which is not typical for their condition.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Tofacitinib, a hair regrowth treatment, may worsen acne.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Oral tofacitinib successfully treated total body hair loss in one patient.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

Alopecia areata can show unusual red-dotted vessels and dithranol treatment may mask typical patterns.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Alopecia areata in infants may be more common than previously thought.

Topical minoxidil can help regrow hair in alopecia areata but is less effective for severe cases.